Evolus Newsroom

Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating

Futu NewsNov 8 21:40

A Quick Look at Today's Ratings for Evolus(EOLS.US), With a Forecast Between $20 to $27

Futu NewsNov 8 21:13

Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Poseida Therapeutics (PSTX) and Evolus (EOLS)

TipRanksNov 8 20:32

Needham Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $22

Futu NewsNov 7 20:35

Evolus Maintains Strong Growth Outlook Despite Earnings Miss: A Buy Recommendation

TipRanksNov 7 19:38

H.C. Wainwright Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $27

Futu NewsNov 7 19:31

Evolus Analyst Ratings

BenzingaNov 7 19:29

HC Wainwright & Co. Reiterates Buy on Evolus, Maintains $27 Price Target

BenzingaNov 7 19:29

Barclays Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $20

Futu NewsNov 7 16:34

Barclays Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $20

Futu NewsNov 6 16:33

Evolus Analyst Ratings

BenzingaNov 1 18:44

H.C. Wainwright Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $27

Futu NewsNov 1 18:36

H.C. Wainwright Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $27

Futu NewsOct 3 18:31

Evolus Is Maintained at Overweight by Barclays

Dow JonesSep 14 00:09

Stifel Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $25

Futu NewsSep 13 21:32

Stifel Nicolaus Reaffirms Their Buy Rating on Evolus (EOLS)

TipRanksSep 13 20:37

Needham Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $22

Futu NewsSep 13 18:31

Evolus Price Target Maintained With a $22.00/Share by Needham

Dow JonesSep 13 18:02

Evolus Buy Rating Justified by Strong Market Positioning and Growth Projections

TipRanksSep 13 17:47

Barclays Maintains Evolus(EOLS.US) With Buy Rating, Raises Target Price to $20

Futu NewsSep 13 15:32